Research Paper Volume 15, Issue 18 pp 9561—9571

Impact of liver metastases status on survival outcomes of first-line immunotherapy in extensive stage small cell lung cancer: a systematic review and meta-analysis

class="figure-viewer-img"

Figure 6. Forest plot illustrating hazard ratios for overall survival between immuno-chemotherapy and chemotherapy. (A) Patients with liver metastases. (B) Patients without liver metastases.